Home12V • FRA
add
Veracyte Inc
Previous close
€21.40
Day range
€21.40 - €21.40
Year range
€17.50 - €26.60
Market cap
1.75B USD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 96.84M | 17.50% |
Operating expense | 47.44M | -10.49% |
Net income | -1.86M | 76.96% |
Net profit margin | -1.92 | 80.45% |
Earnings per share | 0.04 | 134.79% |
EBITDA | 7.57M | 360.70% |
Effective tax rate | 2.31% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 209.19M | 17.59% |
Total assets | 1.20B | 3.71% |
Total liabilities | 81.42M | 7.33% |
Total equity | 1.12B | — |
Shares outstanding | 76.45M | — |
Price to book | 1.46 | — |
Return on assets | 0.43% | — |
Return on capital | 0.45% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.86M | 76.96% |
Cash from operations | -8.97M | -312.80% |
Cash from investing | 2.88M | -88.05% |
Cash from financing | -864.00K | -151.28% |
Net change in cash | -7.06M | -129.86% |
Free cash flow | -3.42M | -28.22% |
About
Founded
2006
Headquarters
Website
Employees
815